ATTGENO AB
Developing targeted nitric oxide delivery drugs for critical care applications.
Oversikt
- 2
- Ansatte
- 0 SEK
- Omsetning
- 2005
- Grunnlagt
Beskrivelse
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556692775101
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Cereno Scientific AB
10–19 ansattePioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
LobSor Pharmaceuticals Aktiebolag
3 ansatteDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
MucoLife Therapeutics AB
1–4 ansatteDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Sangair AB
3 ansatteDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Omnio Healer AB
0 ansatteDeveloping regenerative plasminogen therapy to heal chronic wounds effectively.
Utforsk mer
Spørsmål om ATTGENO AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo